The study findings of the Australian Institute of Health and Welfare (AIHW) and National Breast and Ovarian Cancer Center (NBOCC) released today found that women diagnosed with ductal carcinoma in situ (DCIS) are at a significantly higher risk of being diagnosed with a subsequent invasive breast cancer.
There is a 21 percent higher prostate cancer mortality rate in men of remote and regional Australia as compared to the men in capital cities.
Canadian cancer drugmaker Aeterna Zentaris Inc (AEZ.TO) said on Monday that European health regulators granted its perifosine blood cancer treatment orphan drug status, marking the second such designation for the drug.
Roche, the world's largest maker of cancer drugs, said on Thursday it was the first positive Phase III study of an anti-angiogenic therapy, which uses drugs to stop tumors from making new blood vessels, in advanced ovarian cancer.
Roche had indicated peak sales of the drug for the disease could have hit between 500 million and 1 billion Swiss francs ($466-$933 million), according to Deutsche Bank analysts.
U.S. health regulators approved Roche's (ROG.VX) blockbuster cancer drug Rituxan to treat the most common form of leukemia in adults.
Women who took GlaxoSmithKline's Paxil while taking tamoxifen at the same time were more likely to die of their breast cancer, the researchers found. The longer the overlap between Paxil and tamoxifen, the more likely the patients were to die, they reported in the British Medical Journal.
People who drank mostly fruit juice instead of sodas did not have the same risk, the study of 60,000 people in Singapore found.
Soy contains isoflavones, which act similarly to the hormone estrogen, and may have anti-cancer qualities in hormone-related cancers of the breast and prostate, the researchers note in the American Journal of Clinical Nutrition.
A report by the Geneva-based International Union Against Cancer (UICC) highlighted nine infections that can lead to cancer and urged health officials to drive home the importance of vaccines and lifestyle changes in fighting the disease.
Maikel Peppelenbosch of the University of Groningen in the Netherlands said tests showed that apigenin -- a common component of fruit and vegetables -- was able to halt the development of two kinds of cells in leukemia and cut their survival chances.
They also hope they can use the research to help tailor treatments for children, to spare them radiation and chemotherapy that may do them little good.
A simple see and treat approach using a test costing $2 could help doctors prevent 100,000 cervical cancer deaths a year in women in poorer countries, British scientists said on Friday.
A new QUT study aims to help cancer survivors improve their quality of life, both physically and psychologically, when they have completed their treatment.
The Australian Government today has continued its fight against breast cancer with the announcement that Australian women at risk of breast cancer will be able to be screened by the latest technology as early as next week.
Researchers have found four new genetic variants that increase the risk of contracting one of the major forms of leukemia, confirming that risk factors for the fatal blood cancer can be inherited.
Mammograms should begin at 40 for women with an average risk of breast cancer and by 30 for high-risk women, according to guidelines released on Monday by two groups that specialize in breast imaging, contradicting controversial guidelines from a U.S. advisory panel last year.
Taking a cholesterol-lowering statin will lower your cholesterol but it won't cut your risk of developing colorectal cancer, according to study of more than 400,000 Canadians.
Pfizer Inc (PFE.N) said on Tuesday it has ended a late-stage lung cancer study of its experimental drug figitumumab after an analysis showed it was unlikely to meet the main goal of improving overall survival.
Vical Inc (VICL.O) said it received positive review from an independent board on the late-stage study of its experimental cancer treatment, sending its share up as much as 32 percent.
Compugen Ltd announced the discovery and experimental validation of a new drug target for the treatment of a type of cancer, sending its shares up as much as 41 percent in pre-market trade.
Tumors can not only spread through the body by sending out tiny cells called seeds, but they can re-seed themselves, researchers said in a report on Thursday that may help explain why tumors grow back even after they are removed.